Nrf2-ARE stress response mechanism: A control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases

Free Radical Research

Volumn 44, Issue 11, 2010, Pages 1267-1288

  Singh, Shruti ^a   Vrishni, Sonal ^a   Singh, Brijesh K ^a   Rahman, Irfan ^b   Kakkar, Poonam ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

antioxidant responsive element; inflammation; kelch like ECH associated protein1; nuclear factor erythroid 2 related factor; Oxidative stress; redox homeostasis

Indexed keywords

2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 OIC ACID; ANTIOXIDANT; CURCUMIN; EPOXIDE HYDROLASE; GAMMA INTERFERON; GLUCURONOSYLTRANSFERASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE SYNTHASE; GLUTATHIONE TRANSFERASE; HEAT SHOCK TRANSCRIPTION FACTOR 1; HEME OXYGENASE 1; HISTONE ACETYLTRANSFERASE PCAF; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 1BETA; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PARACETAMOL; PROTEIN C FOS; PROTEIN P300; QUERCETIN; REACTIVE OXYGEN METABOLITE; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ACETYLATION; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; AUTOIMMUNE DISEASE; CANCER RESISTANCE; CARDIOVASCULAR DISEASE; CELL PROTECTION; CELLULAR DISTRIBUTION; DEGENERATIVE DISEASE; DIABETES MELLITUS; ELECTROPHILIC STRESS; EMPHYSEMA; ENVIRONMENTAL STRESS; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; LUNG DISEASE; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REDOX STRESS; REVIEW; STRESS; UPREGULATION;

ANIMALS; CHRONIC DISEASE; HUMANS; INFLAMMATION; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VESICULAR TRANSPORT PROTEINS;

EID: 77958004285     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2010.507670     Document Type: Review

References (235)

1. Mcmillian M, Nie A, Parker JB, Leone A, Kemmerer M, Bryant S, Herlich J, Yieh L, Bittner A, Liu X, Wan J, Johnson MD, Lord P. Drug-induced oxidative stress in rat liver from a toxicogenomics perspective. Toxicol Appl Pharmocol 2005;207(2 Suppl):171-178.
2. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40.
3. Finkel T. Reactive oxygen species and signal transduction. IUBMB Life 2001;52:3-6.
4. Monteiro HP, Stern A. Redox modulation of tyrosine phos-phorylation- dependent signal transduction pathways. Free Radic Biol Med 1996;21:323-333.
5. Ando K, Hirao S, Kabe Y, Ogura Y, Sato I, Yamaguchi Y, Wada T, Handa H. A new APE1/Ref-1 dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 2008;36: 4327-4336.
6. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005;12:1161-1208.
7. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
8. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
9. D'Autrèaux B, Toledano MB. ROS as signaling molecules: mechanisms that generate specifi city in ROS homeostasis. Nat Rev Mol Cell Biol ;2007; 8; 813-824.
10. Pastor N, Weinstein H, Jamison E, Brenowitz M. A detailed interpretation of OH radical footprints in a TBP-DNA complex reveals the role of dynamics in the mechanism of sequence-specifi c binding. J Mol Biol 2000;304:55-68.
11. Uchiyama A, Kim JS, Kon K, Jaeschke H, Ikejima K, Watanabe S, Lemasters JJ. Translocation of iron from lyso-somes into mitochondria is a key event during oxidative stress-induced hepatocellular injury. Hepatology 2008;48: 1644-1654.
12. Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fi brogenesis. Fibrogen Tissue Repair 2008;1:5-62.
13. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003;9(4):169-176.
14. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signaling. Curr Med Chem 2004;11:1163-1182.
15. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med 2000;28:463-499.
16. Moi P, Chan K, Asunis I, Cao A, Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA 1994;91:9926-9930.
17. Motohashi H, Yamamoto M. Nrf2-Keap1 defi nes and physiologically important stress response mechanism. Trends Mol Med 2004;10:549-557.
18. Aleksunes LM, Manautou JE. Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol Pathol 2007;35:459-473.
19. Katoh Y, Iida K, Kang MI, Kobayashi A, Mizukami M, Tong KI, McMahon M, Hayes JD, Itoh K, Yamamoto M. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. Arch Biochem Biophys 2005;433:342-350.
20. Dhakshinamoorthy S, Jaiswal AK. Functional characterization and role of Keap1 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: quinone oxidoreductase1 gene. Oncogene 2001;20:3906-3917.
21. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap-1 represses nuclear activation of anti-oxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999;13:76-86.
22. McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. Redox-regulated turnover of Nrf2 is determined by at least two seperate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 2004;279:31556-31567.
23. Itoh K, Wakabayashi N, Katoh Y, Ishii T, O'Conner T, Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 2003;8:379-391.
24. Xue F, Cooley L. Kelch encodes a component of intercellular bridges in Drosophila egg chambers. Cell 1993;72: 681-693.
25. Kipper LM, Mulchay RT. The Keap-1 BTB/POZ dimeriza-tion function is required to sequester Nrf2 in cytoplasm. J Biol Chem 2002;277:36544-36552.
26. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89-116.
27. McMahon M, Itoh K, Yamamoto M, Hayes JD. Keap1 dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 2003;278:21592-21600.
28. Nguyen T, Sherrat PJ, Huang HC, Yang CS, Pickett CB. Increased protein stability as a mechanism that enhances Nrf2 mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26S protea-some. J Biol Chem 2003;278:4536-4541.
29. Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1-BTB protein is an adapter that bridges Nrf2 to Cul3-based E3 ligase: oxidative stress sensing by Cul3-Keap1 ligase. Mol Cell Biol 2004;24:8477-8486.
30. Kobayashi A, Ohta T, Yamamoto M. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxi-dant and detoxifying enzymes. Methods Enzymol 2004;378: 273-286.
31. Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 2004;24:10941-10953.
32. Furukawa M, Xiong Y. BTB protein Keap1 targets antioxi-dant transcription factor Nrf2 for ubiqutination by the Cullin 3-Roc1 ligase. Mol Cell Biol 2005;25:162-171.
33. McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. Dimerisation of substrate adapter can facilitate cullin-mediated ubiquitylation of proteins by a " tethering " mechanism: a two site interaction model for the Nrf2-Keap1 complex. J Biol Chem 2006;281:24756-24768.
34. Lo SC, Li X, Henzl MT, Beamer LJ, Hannink M. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J 2006;25:3605-3617.
35. Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol 2006;26:2887-2900.
36. Tong KI, Kobayashi A, Katsuoka F, Yamamoto M. Two site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol Chem 2006;387: 1311-1320.
37. Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 2003;23:8137-8151.
38. Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 2006;26:221-229.
39. Copple IM, Goldring CE, Kitteringeham NR, Park BK. The Nrf2-Keap1 pathway: role in protection against drug-induced toxicity. Toxicology 2008; 246:24-33.
40. Lee OH, Jain AK, Papusha V, Jaiswal AK. An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J Biol Chem 2007;282:36412-36420.
41. Hong F, Sekhar KR, Freeman ML, Liebler DC. Specifi c patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J Biol Chem 2005; 280:31768-31775.
42. Sun Z, Huang Z, Zhang DD. Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS One 2009; 4:e6588-e6596 .
43. Yu R, Chen C, Mo YY, Hebbar V, Owuor ED, Tan TH, Kong AN. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J Biol Chem 2000;275:39907-39913.
44. Huang HC. Phosphorylation of Nrf2 at Ser40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002;277:42769-42774.
45. Nguyen T, Sherratt PJ, Pickett CB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003;43: 233-260.
46. Sonenberg N, Hinnebusch AG. New modes of transla-tional control in development, behaviour, and disease. Mol Cell 2007; 28:721-729 .
47. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009;136:731-745.
48. Costa-Mattioli M, Sossin WS, Klann E, Sonenberg N. Translational control of long-lasting synaptic plasticity and memory. Neuron 2009; 61:10-26 .
49. Sun Z, Chin YE, Zhang DD. Acetylation of Nrf2 by p300/ CBP: augment promoter specifi c DNA binding of Nrf2 during the antioxidant response. Mol Cell Biol 2009;29: 2658-2672.
50. Katoh Y, Itoh K, Yoshida E, Miyagishi M, Fukamizu A, Yamamoto M. Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 2001;6:857-868.
51. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996; 87:953-959.
52. Jain AK, Bloom DA, Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem 2005;280: 29158-29168.
53. Li W, Yu SW, Kong AN. Nrf2 posses a redox-sensitive nuclear exporting signal in the Neh 5 transactivation domain. J Biol Chem 2006;281:27251-27263.
54. Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleo-cytoplasmic shuttling by Keap1. J Biol Chem 2005;280: 32485-32492.
55. Velichkova M, Hasson T. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol Cell Biol 2005;25:4501-4513.
56. Jain AK, Jaiswal A K. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J Biol Chem 2006;281: 12132-12142.
57. Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S, Imakado S, Kotsuji T, Otsuka F, Roop DR, Harada T, Engel JD, Yamamoto M. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 2003;35:238-245.
58. Rubiolo JA, Mithieux G, Vega F V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 2008; 591:66-72.
59. Ishii T, Itoh K, Yamamoto M. Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements. Methods Enzymol 2002;348:182-190.
60. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element activation by oxidative stress and identi-fication of the DNA consensus sequence required for functional activity. J Biol Chem 1991;266:11632-11639.
61. Jaiswal AK. Regulation of antioxidant response element-dependent induction of detoxifying enzyme synthesis. Methods Enzymol 2004;378:221-238.
62. Nioi P, McMahon M, Itoh K, Yamamoto M, Hayes JD. Identifi cation of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidore-ductase 1 gene: reassessment of the ARE consensus sequence. Biochem J 2003;374:337-348.
63. Wasserman WW, Fahl WE. Functional antioxidant responsive elements. Proc Natl Acad Sci USA 1997;94:5361-5366.
64. Usami H, Kusano Y, Kumagai T, Osada S, Itoh K, Kobayashi A, Yamamoto M, Uchida K. Selective induction of the tumor marker glutathione S-transferase P1 by protea-some inhibitors. J Biol Chem 2005;280:25267-25276.
65. Favreau LV, Pickett CB. The rat quinone reductase antioxidant response element. J Biol Chem 1995;270: 24468-24474.
66. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung infl ammation: therapeutic approaches. Free Radic Biol Med 2000;28:1405-1420.
67. Moinova HR, Mulcahy RT. An electrophile responsive element (EpRE) regulates β-naphthofl avone induction of the human γ-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. J Biol Chem 1998;273:14683-14689.
68. Alam J, Cook JL. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des 2003;9:2499-2511.
69. Venugopal R, Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 1998;17:3145-3156.
70. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through anti-oxidant response elements. Biochem Biophys Res Commun 1997;236:313-322.
71. Nguyen T, Huang HC, Pickett CB. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J Biol Chem 2000;275: 15466-15473.
72. Zhu M, Fahl WE. Functional characterization of transcription regulators that interact with the electrophile response element. Biochem Biophys Res Commun 2001;289:212-219.
73. Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987;238:1386-1392.
74. Barnett SC, Rosario M, Doyle A, Kilbey A, Lovatt A, Gillespie DA. Differential regulation of AP-1 and novel TRE-specifi c DNA-binding complexes during differentiation of oligodendrocyte-type-2-astrocyte (O-2A) progenitor cells. Development 1995;121:3969-3977.
75. Motohashi H, Shavit JA, Igarashi K, Yamamoto M, Engel JD. The world according to Maf. Nucleic Acids Res 1997;25: 2953-2959.
76. Dhakshinamoorthy S, Jaiswal AK. c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction. Oncogene 2002;21:5301-5312.
77. Curran T, Franza BR, Jr. Fos and Jun: the AP-1 connection. Cell 1988;55:395-397.
78. Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinine oxidoreductase1 gene. Proc Natl Acad Sci USA 1996;93: 14960-14965.
79. Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Bio 2004;37:139-143.
80. Kwak MK, Itoh K, Yamamoto M, Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemo-preventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 2002;22: 2883-2892.
81. Reisman SA, Buckley DB, Tanaka Y, Klaassen CD. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes. T oxicol Appl Pharmacol 2009;236:109-114.
82. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG. NAD(P)H:quinone oxidoreductase (NQO-1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 2002;4:62-70.
83. Ross D. Quinone reductases multitasking in the metabolic world. Drug Metab Rev 2004;36:639-654.
84. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
85. McIlwain CC, Townsend DM, Tew KD. Glutathione S-Transferase polymorphisms: cancer incidence and therapy. Oncogene 2006;25:1639-1648.
86. Nagar S, Remmel RP. Uridine diphosphoglucuronosyl trans-ferase pharmacogenetics and cancer. Oncogene 2006;25: 1659-1672.
87. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-891.
88. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA. Nrf2, a multi-organ protector? FASEB J 2005;19:1061-1066.
89. Chan JY, Kwong M. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta 2000;1517:19-26.
90. Leung L, Kwong M, Hou S, Lee C, Chan JY. Defi ciency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem 2003;278:48021-48029.
91. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modifi ed by inducers. Proc Natl Acad Sci USA 2004;101:2040-2045. (Pubitemid 38229011)
92. Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M. Hepatocyte-specifi c deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun 2006; 339:79-88.
93. Wild AC, Mulchahy RT. Regulation of gamma-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidants defences. Free Radic Res 2000;32:281-301.
94. Chanas SA, Jiang Q, McMahon M, McWalter GK, McLellan LI, Elcombe CR, Henderson CJ, Wolf CR, Moffat GJ, Itoh K, Yamamoto M, Hayes JD. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J 2002;365:405-416.
95. Wild AC, Moinova HR, Mulcahy RT. Regulation of gam-maglutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 1999;274: 33627-33636.
96. Yang H, Magilnick N, Lee C, Kalmaz D, Ou X, Chan JY, Lu SC. Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1. Mol Cell Biol 2005;25:5933-5946.
97. Biswas SK, Rahman I. Environmental toxicity, redox signaling and lung infl ammation: the role of glutathione. Mol Aspects Med 2009;30:60-76.
98. Lee HR, Cho JM, Shin DH, Yong CS, Choi HG, Wakabayashi N, Kwak MK. Adaptive response to GSH depletion and resistance to L-buthionine-(S,R)- sulfoximine: involvement of Nrf2 activation. Mol Cell Biochem 2008; 318:23-31.
99. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, Hagen TM. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA 2004;101: 3381-3386.
100. Banning A, Deubel S, Kluth D, Zhou Z, Brigelius-Flohe R. The GI-GPx gene is a target for Nrf2. Mol Cell Biol 2005; 25:4914-4923.
101. Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, Fujii J, Myers A, Biswal S. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 2009;46:443-453.
102. Hayes JD, Chanas SA, Henderson CJ, McMahon M, Sun C, Moffat GJ, Wolf CR, Yamamoto M. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxy-anisole and ethoxyquin. Biochem Soc Trans 2000;28:33-41.
103. Evans DAP, Seidegrd J, Narayanan N. The GSTM1 genetic polymorphism in healthy Saudi Arabians and Filipinos, and Saudi Arabians with coronary atherosclerosis. Pharmacoge-netics 1996;6:365-367.
104. Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, Schulte GK, Danley DE, Hoth LR, Griffor MC, Kamath AV, Rosner MH, Chrunyk BA, Perregaux DE, Gabel CA, Geoghegan KF, Pandit J. Identifi cation, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem 2000;275:24798-24806.
105. Hayes JD, Pulford DJ. The glutathione S-transferase super-gene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
106. Board PG, Baker RT, Chelvanayagam G, Jermiin LS. Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J 1997;328:929-935.
107. Reddy NM, Kleeberger SR, Yamamoto M, Kensler TW, Scollick C, Biswal S, Reddy SP. Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection. Physiol Genomics 2007;32:74-81.
108. Sherratt PJ, Manson MM, Thomson AM, Hissink EA, Neal GE, van Bladeren PJ, Green T, Hayes JD. Increased bioactivation of dihaloalkanes in rat liver due to induction of class theta glutathione S-transferase T1-1. Biochem J 1998; 335:619-630.
109. Seidegard J, Ekstrom G. The role of human glutathione trans-ferases and epoxide hydrolases in the metabolism of xenobi-otics. Environ Health Perspect 1997;105(Supp 4):791-799.
110. Radjendirane V, Joseph P, Jaiswal AK. Gene expression of DT diaphorase (NQO-1) in cancer cells. In: Forman HJ, Cadenas E, editors. Oxidative stress and signal transduction. New York: Chapman & Hall; 1997. p 441-475.
111. Riley RJ, Workman P. DT diaphorase and cancer chemotherapy. Biochem Pharm ;1992; 43; 1657-1669.
112. Li Y, Jaiswal AK. Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J Biol Chem 1992;267:15097-15104.
113. Bock KW, Kohle C. UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Methods Enzymol 2005;400:57-75.
114. Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, O'Connor T, Harada T, Yamamoto M. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci 2001;59:169-177.
115. Münzel PA, Schmohl S, Buckler F, Jaehrling J, Raschko FT, Kohle C, Bock KW. Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells. Biochem Pharmacol 2003;66:841-847.
116. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler T W. Sensitivity to carcino-genesis is increased and chemoprotective effi cacy of enzyme inducers is lost in nrf2 transcription factor-defi cient mice. Proc Natl Acad Sci USA 2001;98:3410-3415.
117. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005;202:199-211.
118. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004;117:285-297.
119. Pantopoulos K. Iron metabolism and IRE/IRP regulatory system: an update. Ann NY Acad Sci 2004;1012:1-13.
120. Wei W, Di X, D'Agostino RB, Jr, Torti SV, Torti FM. Excess capacity of the Iron regulatory protein system. J Biol Chem 2007;282:24650-24659.
121. Hintze KJ, Theil EC. DNA and mRNA elements with complimentary response to hemin, antioxidant inducer, and iron control ferritin-L expression. Proc Natl Acad Sci USA 2005;102:15048-15052.
122. Pietsch EC, Chan JY, Torti FM, Torti SV. Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J Biol Chem 2003;278: 2361-2369.
123. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxi dase activity. J Biol Chem 2000;275:25122-2512.
124. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM. Ferritin and the response to oxidative stress. Biochem J 2001;357:241-247.
125. Guo X, Shin VY, Cho CH. Modulation of heme oxygenase in tissue injury and its implication in protection against gastrointestinal diseases. Life Sci 2001;69:3113-3119.
126. Prestera T, Talalay P, Alam J, Ahn YI, Lee PJ, Choi AM. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med 1995;1:827-837.
127. Inamdar NM, Ahn YI, Alam J. The heme-responsive element of the mouse hemeoxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. Biochem Biophys Res Commun 1996;221:570-576. (Pubitemid 26153905)
128. Bauer M, Bauer I. Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxid Redox Signal 2008;4:749-758.
129. Chin KV, Pastan I, Gottesman MM. Function and regulation of the multidrug resistance gene. Adv Cancer Res 1993; 60:157-180.
130. Sekhar KR, Crooks PA, Sonar VN, Friedman DB, Chan JY, Meredith MJ, Starnes JH, Kelton KR, Summar SR, Sasi S, Freeman ML. NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols. Cancer Res 2003; 63:5636-5645.
131. Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, Boyer JL. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol 2004;40:585-591.
132. Maher JM, Cheng X, Slitt AL, Dieter MZ, Klaassen CD. Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 2005;33:956-962.
133. Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong AN. Gene expression profi les induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/ Nrf2 (-/-) mice. Cancer Lett 2006;243:170-192.
134. Jin W, Wang H, Yan W, Xu L, Wang X, Zhao X, Yang X, Chen G, Ji Y. Disruption of Nrf2 enhances upregulation of NF-kB activity, proinfl ammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Infl am 2008;725174.
135. Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clinic Invest 2006;116:984-995.
136. Kim YC, Masutani H, Yamaguchi Y, Itoh K, Yamamoto M, Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J Biol Chem 2001;276:18399-18406.
137. Katzman R. Alzheimer's disease. N Engl J Med 1986;314: 964-973. (Pubitemid 16129832)
138. Perry G, Castellani RJ, Hirai K, Smith MA. Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimers Dis 1998;1:45-55.
139. Mariani E, Polidori MC, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 2005;827:65-75.
140. de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, van Horssen J. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic Biol Med 2008;45:1375-1383.
141. Innamorato NG, Rojo AI, Garcia-Yague AJ, Yamamoto M, de Ceballos ML, Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain infl ammation. J Immunol 2008;181:680-689.
142. Innamorato NG, Lastres-Becker I, Cuadrado A. Role of microglial redox balance in modulation of neuroinfl amma-tion. Curr Opin Neurol 2009;22:308-314.
143. Cummings JL. Alzheimer's disease. N Engl J Med 2004; 351:56-67.
144. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997;23:134-147.
145. Shcherbatykh I, Carpenter DO. The role of metals in the etiology of Alzheimer's disease. J Alzheimers Dis 2007;11: 191-205.
146. Sultana R, Perluigi M, Butterfi eld DA. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid Redox Signal 2006;8: 2021-2037.
147. Volke W, Sicilia T, Pahler A, Gsell W, Tatschner T, Jellinger K, Leblhuber F, Riederer P, Lutz WK, Gotz ME. Increased brain levels of 4-hydroxy-2-nonel glutathione conjugates in severe Alzheimer's disease. Neurochem Int 2006;48:679-686.
148. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994;36:747-751.
149. Wang J, Xion S, Xie C, Markesbery WR, Lovell MA. Increased oxidative stress in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005;93:953-962.
150. Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT, Jordan-Sciutto KL. Expression of Nrf2 in neurodegenerative diseases. J Neuro pathol Exp Neurol 2007;66:75-85.
151. Rizzu P, Hinkle DA, Zhukareva V, Bonifati V, Severijnin LA, Martinez D, Ravid R, Kamphorst W, Eberwine JH, Lee VM, Trojanowski JQ, Heutink P. DJ-1 colocalizes with tau inclusions: a link between Parkinsonism and dementia. Ann Neurol 2004;55:113-118.
152. Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL. The oxidation state of DJ-1 regulates its chaperon activity towards alpha-synuclein. J Mol Biol 2006;356:1036-1048.
153. Kumaran R, Kingsbury A, Coulter I, Lashley T, Williams D, de Silva R, Mann D, Revesz T, Lees A, Bandopadhyay R. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal glial inclusions in neurodegenerative disorders. Neurobiol Dis 2007;28:122-132.
154. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. DJ-1, a cancer-and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 2006;103:15091-15096.
155. Cuadrado A, Moreno-Murciano P, Pedraza-Chaverri J. The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease. Expert Opin Ther Targets 2009;13: 319-329.
156. Wruck CJ, Claussen M, Fuhrmann G, Römer L, Schulz A, Pufe T, Waetzig V, Peipp M, Herdegen T, Götz ME. Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl 2007;72:57-67.
157. Li HY, Zhong YF, Wu SY, Shi N. NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells. Chem Res Toxicol 2007;20: 1242-1251.
158. Walker FO. Huntington's Disease. Semin Neurol 2007;27: 143-150.
159. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo . Cell 1997;90:549-558.
160. Mann VM, Cooper JM, Javoy-Agid F, Agid Y, Jenner P, Schapira AH. Mtochondrial function and parental sex effect in Huntington's disease. Lancet 1990;336:749.
161. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996;39:385-389.
162. Ferrante RJ, Andreassen OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Kaddurah-Daouk R, Hersch SM, Beal MF. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci 2000; 20:4389-4397.
163. Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, Friedlich A, Browne SE, Schilling G, Borchelt DR, Hersch SM, Ross CA, Beal MF. Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiol Dis 2001;8:479-491.
164. Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, Como P, Zimmerman C, Lin M, Zhang L, Ulug AM, Beal MF, Matson W, Bogdanov M, Ebbel E, Zaleta A, Kaneko Y, Jenkins B, Hevelone N, Zhang H, Yu H, Schoenfeld D, Ferrante R, Rosas HD. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology 2006;66:250-252.
165. van Roon-Mom WM, Pepers BA,'t Hoen PA, Verwijmeren CA, den Dunnen JT, Dorsman JC, van Ommen GB. Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease. BMC Mol Biol 2008;9:84-96.
166. Yan W, Wang HD, Zhu L, Feng XM, Qiao L, Jin W, Tang K. Traumatic brain injury induces the activation of the Nrf2-ARE pathway in the lung in rats. Brain Inj 2008; 22:802-810.
167. Manne GE, Bonacasa B, Ishii T, Siow RC. Targeting the redox sensitive Nrf2-Keap-1 defense pathway in cardiovascular disease: protection afforded by dietary isofl avones. Curr Opin Pharmacol 2009;9:139-145.
168. Langston W, Circu ML, Aw TY. Insulin stimulation of gamma- glutamylcysteine ligase catalytic subunit expression increases endothelial GSH during oxidative stress: infl uence of low glucose. Free Radic Biol Med 2008;45:1591-1599.
169. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signaling. Cardiovasc Res 2009;82:9-20.
170. Zakkar M, Van der Heiden K, Luong le A, Chaudhury H, Cuhlmann S, Hamdulay SS, Krams R, Edirisinghe I, Rahman I, Carlsen H, Haskard DO, Mason JC, Evans PC. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinfl ammatory state. Arterioscler Thromb Vasc Biol 2009;29:1851-1857.
171. Tanaka Y, Aleksunes LM, Yeager RL, Gyamfi MA, Esterly N, Guo GL, Klaassen CD. NF-E2 related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high fat diet. J Pharmacol Exp Ther 2008;325:655-664.
172. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, Kleeberger SR. Role of Nrf2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 2002;26:175-182.
173. Cho HY, Reddy SP, Yamamoto M, Kleeberger SR. The transcription factor NRF2 protects against pulmonary fi brosis. FASEB J 2004;18:1258-1260.
174. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway infl ammation and asthma in mice. J Exp Med 2005;202:47-59.
175. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999;31: 273-300.
176. Jardine H, MacNee W, Donaldson K, Rahman I. Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells: involvement of AP-1/ARE and Fra-1. J Biol Chem 2002;277:21158-21166.
177. Bakin AV, Stourman NV, Sekhar KR, Rinehart C, Yan X, Meredith MJ, Arteaga CL, Freeman ML. Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding Phase II detoxifying proteins. Free Radic Biol Med 2005; 38:375-387.
178. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004;114:1248-1259.
179. Iizuka T, Ishii Y, Itoh K, Kiwamoto T, Kimura T, Matsuno Y, Morishima Y, Hegab AE, Homma S, Nomura A, Sakamoto T, Shimura M, Yoshida A, Yamamoto M, Sekizawa K. Nrf2-defi cient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 2005;10:1113-1125.
180. Sussan TE, Rangasamy T, Blake DJ, Malhotra D, El-Haddad H, Bedja D, Yates MS, Kombairaju P, Yamamoto M, Liby KT, SpornMB, Gabrielson KL, Champion HC, Tuder RM, Kensler TW, Biswal S. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci 2009;106:250-255.
181. Harju T, Kaarteenaho-Wiik R, Soini Y, Sormunen R, Kinnula VL. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers'lung. Am J Respir Crit Care Med 2002;166:754-759.
182. Malhotra D, Thimmulappa R, Navas-Acien A, Sandford A, Elliott M, Singh A, Chen L, Zhuang X, Hogg J, Pare P, Tuder RM, Biswal S. Decline in Nrf2 regulated antioxidants in COPD lungs due toloss of its positive regulator DJ-1. Am J Respir Crit Care Med 2008;178:592-604.
183. Goven D, Boutten A, Lecon-Malas V, Marchal-Somme J, Amara N, Crestani B, Fournier M, Leseche G, Soler P, Boczkowski J, Bonay M. Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax 2008;63:916-924.
184. Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, Kondo S, Nishimura M. Downregulated NF-E2-related Factor 2 in pulmonary macrophages of aged smokers and COPD patients. Am J Respir Cell Mol Biol 2008;39:673-682.
185. Cho HY, Kleeberger SR. Nrf2 protects against airway disorders. Toxicol Appl Pharmacol 2010;244:43-56.
186. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 2005;7:32-41.
187. Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2008;294:L478-L488.
188. Cho HY, Imani F, Miller-DeGraff L, Walters D, Melendi GA, Yamamoto M, Polack FP, Kleeberger SR. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am J Respir Crit Care Med 2009;179:138-150.
189. Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT, Wong PK, Zhang DD. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 2008; 29:1235-1243 .
190. Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD. Dual roles of Nrf2 in cancer. Pharmacol Res 2008;58:262-270.
191. Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, Kang MI, Kobayashi A, Yokoyama S, Yamamoto M. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 2006;21:689-700.
192. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, Shibata T, Yamamoto M, Hirohashi S. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 2008;68:1303-1309.
193. Wang K, Fang H, Xiao D, Zhu X, He M, Pan X, Shi J, Zhang H, Jia X, Du Y, Zhang J. Converting redox signaling to apoptotic activities by stress-responsive regulators HSF1 and NRF2 in fenretinide treated cancer cells. PLoS One 2009;4:e7538.
194. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51:794-798.
195. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000;407:390-395.
196. Johnson DA, Amirahmadi S, Ward C, Fabry Z, Johnson JA. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci 2010;114:237-246.
197. Rangasamy T, Williams MA, Bauer S, Trush MA, Emo J, Georas SN, Biswal S. Nrf2 inhibits the maturation of murine dendritic cells by Ragweed extract. Am J Respir Cell Mol Biol 2009:doi:10.1165/rcmb.2008-0438OC.
198. Li N, Nel AE. Role of the Nrf2-mediated signaling pathway as a negative regulator of infl ammation: implications for the impact of particulate pollutants on asthma. Antioxid Redox Signal 2006;8:88-98.
199. He X, Chen MG, Ma Q. Activation of Nrf2 in defense against cadmium-induced oxidative stress. Chem Res Toxicol 2008;21:1375-1383.
200. Casalino E, Calzaretti G, Landriscina M, Sblano C, Fabiano A, Landriscina C. The Nrf2 transcription factor contributes to the induction of alpha-class GST isoenzymes in liver of acute cadmium or manganese intoxicated rats: comparison with the toxic effect on NAD(P)H:quinone reductase. Toxicology 2007;237:24-34.
201. O'Hara KA, Nemec AA, Alam J, Klei LR, Mossman BT, Barchowsky A. Chromium (VI) inhibits heme oxygenase-1 expression in vivo and in arsenic-exposed human airway epithelial cells. J Cell Physiol 2006;209:113-121.
202. Knight TR, Kurtz A, Bajit ML, Hinson JA, Jaeschke H. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 2001;62:212-220.
203. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003;31:1499-506.
204. Jaeschke H, Knight TR, Bajit ML. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotox-icity. Toxicol Lett 2003;144:279-288.
205. Chan K, Han XD, Kan YW. An important function of Nrf2 in combating oxidative stress: detoxifi cation of acetaminophen. Proc Natl Acad Sci 2001;98:4611-4616.
206. Osburn WO, Kensler TW. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat Res 2008;659:31-39.
207. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 2001;98:3404-3409.
208. Lo AH, Liang YC, Lin-Shiau SY, Ho CT, Lin JK. Carnosol, an antioxidant in rosemary, suppress inducible inducible nitric oxide synthase through down regulating NF-κ B in mouse macrophage. Carcinogenesis 2002;23:983-999.
209. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, Motterlini R. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the anti-oxidant-responsive element. Biochem J 2003;371:887-895.
210. Garg R, Gupta S, Maru GB. Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis 2008;29:1022-1032.
211. Yang C, Zhang X, Fan H, Liu Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009;1282:133-141.
212. Mandal MN, Patlolla JM, Zheng L, Agbaga MP, Tran JT, Wicker L, Kasus-Jacobi A, Elliott MH, Rao CV, Anderson RE. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med 2009;461: 672-679.
213. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2008;2:351-374.
214. Iqbal M, Sharma SD, Okazaki Y, Fujisawa M, Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 2003;92:33-38.
215. Dinkova-Kostova AT. Protection against cancer by plant phenylpropenoids: induction of mammalian anticarcino-genic enzymes. Mini Rev Med Chem 2002;2:595-610.
216. Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, Galarreta CM, Cuadrado A. Regulation of heme oxygen-ase-1 expression through the phosphatidylinositol 3-kinase/ Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 2004;279:8919-8929.
217. Juge N, Mithen RF, Traka M. Molecular basis for chemo-prevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 2007;64:1105-1127.
218. Kassie F, Sundermann VM, Edenharder R, Platt KL, Darroudi F, Lhoste E, Humbolt C, Muckel E, Uhl M, Kundi M, Knasmuller S. Development and application of test methods for the detection of dietary constituents which protect against heterocyclic aromatic amines. Mutat Res 2003;523-524:183-192.
219. Chen C, Pung D, Leong V, Hebbar V, Shen G, Nair S, Li W, Kong AN. Induction of detoxifying enzymes by Garlic organosulphur compounds through transcription factor. Nrf2: effect of chemical structure and stress signals. Free Rad Biol Med 2004;37:1578-1590.
220. Tanigawa S, Fujii M, Hou DX. Action of Nrf2 and Keap1 in ARE-mediated NQO-1 expression by quercetin. Free Radic Biol Med 2007;42:1690-1703.
221. Choi BM, Kim BR. Upregulation of heme oxygenase-1 by brazilin via the phosphotidylinositol 3-kinase/Akt and ERK pathways and its protective effect against oxidative injury. Euro J Pharma 2008;580:12-18.
222. Habeos IG, Ziros PG, Chartoumpekis D, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG. Simvastatin activates Keap1/Nrf2 signaling in rat liver. J Mol Med 2008;86: 1279-1285.
223. Rojo AI, Innamorato NG, Martín-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A. Nrf2 regulates microglial dynamics and neuroinfl ammation in experimental Parkinson's disease. Glia 2010;58:588-598.
224. Vargas MR, Johnson JA. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med 2009;11:e17.
225. Jin W, Wang H, Yan W, Zhu L, Hu Z, Ding Y, Tang K. Role of Nrf2 in protection against traumatic brain injury in mice. J Neurotrauma 2009;26:31-39.
226. Liu M, Grigoryev DN, Crow MT, Haas M, Yamamoto M, Reddy SP, Rabb H. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int 2009;76:277-285.
227. Mann GE, Bonacasa B, Ishii T, Siow RC. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isofl avones. Curr Opin Pharmacol 2009;9:139-145.
228. Boon RA, Horrevoets AJ. Key transcriptional regulators of the vasoprotective effects of shear stress. Hamostaseologie 2009;29:39-40.
229. Malhotra D, Thimmulappa R, Vij N, Navas-Acien A, Sussan T, Merali S, Zhang L, Kelsen SG, Myers A, Wise R, Tuder R, Biswal S. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med 2009;180:1196-207.
230. Reddy NM, Suryanarayana V, Kalvakolanu DV, Yamamoto M, Kensle TW, Hassoun PM, Kleeberger SR, Reddy SP. Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-defi cient mice. J Immunol 2009;183:4601-4608.
231. Nichols DP, Ziady AG, Shank SL, Eastman JF, Davis PB. The triterpenoid CDDO limits infl ammation in preclinical models of cystic fi brosis lung disease. Am J Physiol Lung Cell Mol Physiol 2009;297:828-836.
232. Song MY, Kim EK, Moon WS, Park JW, Kim HJ, So HS, Park R, Kwon KB, Park BH. Sulforaphane protects against cytokine-and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway. Toxicol Appl Pharmacol 2009;235:57-67.
233. Schreibelt G, van Horssen J, van Rossum S, Dijkstra CD, Drukarch B, de Vries HE. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev 2007;56:322-330.
234. Lee JM, Chan K, Kan YW, Johnson JA. Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia. Proc Natl Acad Sci USA 2004;101:9751-9756.
235. Hong YB, Kang HJ, Kwon SY, Kim HJ, Kwon KY, Cho CH, Lee JM, Kallakury BV, Bae I. Nuclear factor (Erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells. Pancreas 2010;39:463-472.